Xconomy Boston

Antisoma Plc Acquires Xanthus Pharmaceuticals, Inc. for $52,200,000

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6391d6ef-a6ee-4544-9993-5545f3fe5225&Preview=1
Date
5/16/2008
Company Name
Xanthus Pharmaceuticals, Inc.
Mailing Address
300 Technology Square Cambridge, MA 02139
Company Description
Xanthus is a biopharmaceutical company focused on the discovery, development, acquisition and commercialization of small-molecule therapeutics for the treatment of cancer and autoimmune disorders.
Website
http://www.xanthus.com
Transaction Type
M&A
Transaction Amount
$52,200,000
Transaction Round
Proceeds Purposes
M&A Terms
The acquisition will be paid for with Antisoma shares.